AKT1 and gastric cancer: Moreover, by inhibiting PI3K/AKT/mTOR pathway, TA can significantly increase the autophagy level of HepG2/2.2.15 cells and gastric cancer HGC-27 cells, leading to autophagy death of tumor cells [18].